ISO Accreditation
Imspex proudly announces its successful renewal of annual registration to ISO 13485:2016 for Medical Devices – Quality Systems – Requirements for Regulatory Purposes. This achievement follows comprehensive audits of Imspex Diagnostics’ design, development, and manufacturing operations at its Abercynon headquarters in the UK. The recommendation for registration was provided by Eurofins, a prominent international certification […]
ONELAB Annual Meeting
IMSPEX, as part of the ONELAB European Horizon project, attended the annual meeting held at Ghent University, Belgium, marking the first year completion of the visionary collaboration. The international scientists, data and software engineers, project managers and clinical researches marked the occasion with presentations and workshops of the incredible developments undertake over the last year. […]
ONELAB Installations
Imspex is pleased to announce the successful installation of the Breathspec® instrument at Saitama Medical Centre Hospital (SMCH), Saitama, Japan, an institution affiliated with the Educational Corporation Saitama Medical University. This achievement is part of the ONELAB project, an initiative funded by the EU Horizon program to orchestrate next-generation mobile modular laboratories for pandemic monitoring […]
Bevan Commission NHS 75 Conference
5th – 6th July 2023 Our Group CEO John McKinley ,Technical Director Emma Brodrick and PR, Social Media and Marketing Manager Amber Jacobs ACIM will be in attendance hosting our exhibiting stand with our BreathSpec® V2 device. We look forward to seeing you there! Discover more at: https://www.bevancommission.org/tipping-point/
LSX World Congress 2023
3rd – 4th May 2023 Our Group CEO John McKinley will be presenting in the MEDTECH Showcase on the 3rd May at 17:30 as part of the LSX World Congress 2023 Event in London. Our Technical Director Emma Brodrick will also be in attendance to discuss Imspex’s future in next generation point-of-care testing. Discover more […]
AngloNordic Life Science Conference 2023
Our Group CEO John McKinley and PR, Social Media and Marketing Manager Amber Jacobs will be attending the 19th Annual AngloNordic Life Science Conference 2023 on 20th April at the County Hall in London. We look forward to seeing you there! Discover more at https://www.anglonordiclifescience.com/
ECCMID 2023
Our Group CEO John McKinley will be attending the ECCMID 2023 in Copenhagen, Denmark on Monday 17th April. We look forward to seeing you there! Discover more at: https://www.eccmid.org/
MediWales Connects NHS Collaboration Conference 2023
29th June 2023 Our Group CEO John McKinley ,Technical Director Emma Brodrick and PR, Social Media and Marketing Manager Amber Jacobs ACIM will be in attendance hosting our exhibiting stand with our BreathSpec® V2 device. We look forward to seeing you there! Discover more at: https://mediwalesconnects.com/
Arab Health 2023
Our Group CEO, John McKinley will be joining the Welsh Government and ABHI UK Pavilion at Arab Health 2023 in Dubai, UAE from Monday 30th January – Thursday 2nd February on behalf of Imspex seeking growth capital, leading development and commercialisation partners. He will be situated in Hall2 Stand D30. John will also be presenting […]
Imspex is looking for a consortium
IMSPEX is looking for a consortium in the ihi call 3: Screening platform and biomarkers for prediction and prevention of diseases of unmet public health need. IMSPEX are pioneers in Gas Chromatography Ion Mobility Spectrometry (GC-IMS) technology, delivering fast, accurate, lab-quality analysis on-line, at-site, in the laboratory and at point-of-care. Improving outcomes for people remains […]
Group B Streptococcus
Group B streptococcus (GBS) is a common bacterium found in the vagina of about 2 in 10 women in the UK. Being a carrier is not harmful to you, however, many babies come into contact with GBS during labour. The vast majority of babies will suffer no ill effects. However, if GBS is passed from […]
Urine analysis for disease diagnostics or rapid screening
IMSPEX are working closely with partners to develop rapid screening tests using urine analysis. Direct headspace of urine allows rapid analysis of the volatile organic compounds (VOCs) in the sample, which has the potential to diagnose or triage a patient with suspected disease. See the work carried out so far here: Prostate and Bladder Cancers: […]